The Central Commission for Discipline Inspection issued a document referring directly to the medical representative

1 directly refers to the pharmaceutical representatives on January 17, the Central Commission for Discipline Inspection, the State Supervision Commission website published "new regulations restricting the behavior of pharmaceutical representatives cut off the drug rebate interest chain" shows that the pharmaceutical industry ushered in more stringent supervision.
Shanghai Sixth People's Hospital Party Committee Deputy Secretary, Secretary of the Commission for Discipline Inspection, said that in order to open up drug sales channels, improve drug prices and other purposes, some pharmaceutical representatives by sending rebates to doctors to influence their drug use behavior, become a breeding ground for corruption, and to a certain extent led to inflated drug prices.
A case information disclosed by the China Referee's Papers Network shows that the former director of the anesthesiology department of Zhejiang Provincial People's Hospital has repeatedly received benefits from a company's pharmaceutical representative, Ye, and that a drug called Zosin injection alone has collected a cumulative rebate of more than 1.25 million yuan.
It is understood that, as a formal occupation, the work of pharmaceutical representatives mainly includes four aspects: First, the formulation of pharmaceutical product promotion plans and programs;
can be seen that this profession originally has a strong academic promotion meaning.
However, in practice, some pharmaceutical companies directly linked the sales performance of pharmaceutical representatives to income, driven by interests, the nature of the work of many pharmaceutical representatives is distorted into pharmaceutical sales, which has become a frequent problem of corruption in the medical field, drug sales model is prohibited one of the reasons.
colleagues also said that the rebate problem is very harmful, but the blame should not be entirely attributed to the medical representatives.
some pharmaceutical companies in the operating concept of deviation is the deeper reason.
statistics, between 2016 and 2019, more than half of the country's 100 compulsory drug companies were found to have directly or indirectly given kickbacks.
2nd, researchers at Nanjing University's business school published an article in the journal China Market analyzing the introduction of pharmaceutical representatives to foreign pharmaceutical companies in China, which is not strictly what is believed to be Xi'an Yangsen.
Lilly Pharmaceuticals opened its first overseas office in Shanghai in 1918, pharmaceutical representatives were already in Shanghai, Beijing and other cities.
the 1990s, China's medical level and the international gap is large, foreign pharmaceutical representatives entered the Chinese market, first of all as a bridge between China's medical training and knowledge renewal, when medical representatives to the hospital is very popular.
Such as in 1994, a pharmaceutical company leader in a county-level city in Sunan People's Hospital opened a drug recommendation meeting, the hospital outpatient building hung "welcome medical representatives to visit the guidance work" words, and there are local television interviews.
at that time to carry out product sales environment is quite simple, do a good job of marketing, the other is commercial statistics collection can be.
the marketing here include: the introduction of good product characteristics, prices, adaptive disorders, etc. , there are pharmaceutical and medical majors, can clearly express the important.
since 2000, the academic promotion competition of foreign enterprises has entered the white heat, and the nature of marketing has gradually begun to change.
hospital monitoring and promotion data show that about 70% of visits do not leave specific product information to doctors.
most of the visits, doctors can only remember that a representative of a company's drug came to look for the drug is for a disease, can recall a specific product information less.
, 70% of visits lasted 5-10 minutes and 12% lasted less than 5 minutes.
85 percent of visits are considered repetitive by doctors, and most medical representatives still fail to impress doctors, making it harder to influence the way doctors prescribe.
researchers at China Pharmaceutical University have said that information communication is essential between the two major pharmaceutical industries, and that it is common for medical representatives to contact medical institutions in every country in the world.
But in our country at present this kind of medicine is difficult to split the system, the pharmaceutical representative has become the pharmaceutical marketing representative, their work is no longer to carry out academic promotion, but carry the index to carry out drug marketing, and even with gold sales, bribery of doctors and other unfair competition behavior.
3 overall level needs to be improved Quanzhou City, Fujian Province, the first hospital related personnel have issued an article that China's medical representatives after a number of periods of development, but because of the introduction of a short time, so far the development has not been perfect.
As far as the current situation of the profession of pharmaceutical representatives in China is concerned, because the professional roles are mostly determined directly by medical institutions, the lack of professional training and awareness of relevant laws and regulations, resulting in the medical representatives in the follow-up professional practice process as the same drug sales staff basically the same work.
Under the current relevant management system model, pharmaceutical enterprises mainly emphasize to improve the sales of pharmaceutical representatives themselves, so in the course of the actual work, many types of serious problems began to be exposed to people's horizons, so that career development into occupational dilemmas, institutional dilemmas, governance dilemmas and other multiple dilemmas.
Nanjing University of Traditional Chinese Medicine has conducted a survey of 200 medical representatives in Jiangxi, found that the average quality level score of 54.7 ±4.42), less than 80% of the full score, indicating that the overall quality is not high, and the industry on the quality of pharmaceutical representatives there is a greater distance.
may be: 1, the entry threshold of pharmaceutical companies is too low.
pharmaceutical companies in the selection of pharmaceutical representatives, pay more attention to market development, sales ability assessment, education, professional, quality and drug knowledge requirements are not high, resulting in pharmaceutical representatives of pharmaceutical knowledge is generally not high.
2, the recruitment review is not strict.
some pharmaceutical enterprises do not review, assess or train the pharmaceutical representatives employed, and the teams of pharmaceutical representatives formed by the regional general agents themselves are not included in the overall management of pharmaceutical enterprises.
a small number of enterprises to hire sales staff at will, the quality of pharmaceutical representatives is uneven.
3, qualification certificate materials management is not strict.
some pharmaceutical companies will be stamped with a license, business license and a legal representative signed blank power of attorney, blank contract and delivery slip to the hands of each sales representative, let it fill in.
4, different pharmaceutical representatives of the sales model is not uniform.
functions and powers of medical representatives are also different, which make it difficult to standardize management.